Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • PHARMERICA CORP Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY
    Assets
    Cash and Short Term Investments 41.30 M 32.00 M 479.56 M 1.38 M —
    Net Receivables 219.30 M 213.00 M 70.36 M 57.38 M —
    Total Inventories 73.40 M 77.90 M 27.98 M 24.24 M —
    Progress Payments & Others — — — — —
    Prepaid Expenses 0.00 0.00 0.00 — —
    Other Current Assets 41.60 M 46.60 M 10.38 M 11.62 M —
    Current Assets Total 375.60 M 369.50 M 588.27 M 94.62 M —
    Long Term Receivables 0.00 0.00 0.00 0.00 —
    Investment in Unconsolidated Subsidiaries 0.00 0.00 0.00 0.00 —
    Other Investments 0.00 0.00 0.00 0.00 —
    Property, Plant & Equipment Net 54.00 M 57.40 M 24.38 M 17.99 M —
    Property, Plant & Equipment Gross 97.10 M 87.40 M 38.69 M 27.42 M —
    Accumulated Depreciation 43.10 M 30.00 M 14.32 M 9.43 M —
    Other Assets 190.20 M 194.40 M 99.96 M 82.01 M —
    Deferred Charges 0.00 0.00 0.00 0.00 —
    Tangible Other Assets 3.10 M 5.60 M 16.71 M 7.68 M —
    Intangible Other Assets 187.10 M 188.80 M 83.25 M 74.33 M —
    Total Assets 619.80 M 621.30 M 712.61 M 194.62 M —
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt — — — — —
    Accrued Payroll 36.30 M 40.50 M 14.94 M 11.18 M —
    Income Taxes Payable 0.00 0.00 0.00 0.00 —
    Dividends Payable 0.00 0.00 0.00 0.00 —
    Other Current Liabilities 12.60 M 8.90 M 2.55 M 1.67 M —
    Current Liabilities Total 103.30 M 100.90 M 33.30 M 22.32 M —
    Long Term Debt 240.00 M 250.00 M 275.34 M 0.00 —
    Provision for Risks & Charges 0.00 0.00 0.00 0.00 —
    Deferred Taxes -59.40 M -58.80 M 1.36 M 1.76 M —
    Deferred Income 0.00 0.00 215,000.00 158,000.00 —
    Deferred Tax Liability in Untaxed Reserves — — — — —
    Other Liabilities 16.10 M 15.60 M 0.00 0.00 —
    Total Liabilities 300.00 M 307.70 M 310.21 M 24.23 M —
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 —
    Minority Interest 0.00 4.40 M 3.61 M 0.00 —
    Preferred Stock 0.00 0.00 0.00 0.00 —
    Common Equity 319.80 M 309.20 M 398.79 M 170.39 M —
    Common Stock 300,000.00 300,000.00 1,000.00 — —
    Capital Surplus 338.70 M 332.90 M — — —
    Revaluation Reserves 0.00 0.00 — — —
    Other Appropriated Reserves -2.60 M 118.57 M — — —
    Unappropriated (Free) Reserves 0.00 0.00 0.00 0.00 —
    Retained Earnings -16.40 M -21.40 M 51.82 M — —
    Equity in Untaxed Reserves — — — — —
    ESOP Guarantees 0.00 0.00 0.00 — —
    Unrealized Foreign Exchange Gain (Loss) -2.80 M -2.60 M 0.00 — —
    Unrealized Gain (Loss) on Marketable Securities 0.00 0.00 0.00 — —
    Treasury Stock 0.00 0.00 0.00 0.00 —
    Total Liabilities & Shareholders Equity 619.80 M 621.30 M 712.61 M 194.62 M —
    Common Shares Outstanding 30.48 M 30.36 M 30.00 M — —